| Income Statement |
| Operating Expenses | 16.16M |
|
| Research and Development Expense | 11.70M |
| Selling, General and Administrative Expense | 4.46M |
| Operating Income | -16.15M |
| Net Income | -15.15M |
| Net Income Common Stock | -15.15M |
| Net Income Common Stock (USD) | -15.15M |
| Consolidated Income | -15.15M |
| Earnings per Basic Share | -0.12 |
| Earnings per Basic Share (USD) | -0.12 |
| Earnings per Diluted Share | -0.12 |
| Earning Before Interest & Taxes (EBIT) | -15.15M |
| Earning Before Interest & Taxes (USD) | -15.15M |
| Weighted Average Shares | 129.78M |
| Weighted Average Shares Diluted | 129.78M |
| Balance Sheet |
| Cash and Equivalents | 63.30M |
| Cash and Equivalents (USD) | 63.30M |
| Investments | 146.00M |
| Investments Current | 145.00M |
| Investments Non-Current | 1000.00K |
| Current Assets | 213.27M |
| Property, Plant & Equipment Net | 4.51M |
| Total Assets | 220.67M |
| Total Debt | 1.80M |
| Current Liabilities | 7.73M |
| Debt Non-Current | 1.80M |
| Total Liabilities | 9.53M |
| Accumulated Retained Earnings (Deficit) | -460.45M |
| Accumulated Other Comprehensive Income | -63.00K |
| Shareholders Equity | 211.14M |
| Shareholders Equity (USD) | 211.14M |
| Assets Non-Current | 7.39M |
| Total Debt (USD) | 1.80M |
| Liabilities Non-Current | 1.80M |
| Trade and Non-Trade Payables | 3.94M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 302.00K |
| Net Cash Flow from Financing | 128.01M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -27.12M |
| Capital Expenditure | -141.00K |
| Issuance (Purchase) of Equity Shares | 128.02M |
| Net Cash Flow from Investing | -144.95M |
| Net Cash Flow - Investment Acquisitions and Disposals | -144.80M |
| Net Cash Flow from Operations | -10.18M |
| Share Based Compensation | 2.73M |